Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: A randomized controlled trial

JAMA

Volumn 304, Issue 21, 2010, Pages 2363-2372

  Kowey, Peter R ^a,b   Reiffel, James A ^c   Ellenbogen, Kenneth A ^d   Naccarelli, Gerald V ^e   Pratt, Craig M ^f,g  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

^f HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DYSGEUSIA; DYSPEPSIA; ELECTROCARDIOGRAM; ERUCTATION; FEMALE; FLATULENCE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HUMAN; INSOMNIA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; SINUS RHYTHM; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; UPPER ABDOMINAL PAIN; VOMITING;

EID: 78649782185     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1735     Document Type: Article

References (26)

1. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119(18):2516- 2525.
2. Friberg J, Buch P, Scharling H, Gadsbphioll N, Jensen GB. Rising rates of hospital admissions for atrial fibrillation. Epidemiology. 2003;14(6):666-672. (Pubitemid 40417013)
3. Singh SN, Patrick J, Patrick J. Antiarrhythmic drugs. Curr Treat Options Cardiovasc Med. 2004;6(5):357-364.
4. Podrid PJ. Proarrhythmia, a serious complication of antiarrhythmic drugs. Curr Cardiol Rep. 1999;1(4):289-296.
5. Fuster V, Rydén LE, Cannom DS, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7):e257-e354.
6. Reiffel JA, McDonald A. Antiarrhythmic effects of omega-3 fatty acids. Am J Cardiol. 2006;98(4A):50i-60i.
7. Xiao YF, Sigg DC, Leaf A. The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism. J Membr Biol. 2005;206(2):141-154.
8. Saravanan P, Bridgewater B, West AL, O'Neill SC, Calder PC, Davidson NC. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol. 2010;3(1):46-53.
9. Calò L, Bianconi L, Colivicchi F, et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol. 2005;45(10):1723-1728.
10. Nodari S, Triggiani M, Foresti A, et al. Use of N-3 polyunsaturated fatty acids to maintain sinus rhythm after conversion from persistent atrial fibrillation: a prospective randomized study. J Am Coll Cardiol. 2010;55(10A):e14.
11. Sandesara C, Chung MK, Van Wagoner DR, et al. Fish oil to inhibit supraventricular arrhythmias after cardiac surgery: the FISH trial. Paper presented at: the Heart Rhythm Society meeting; May 12-15, 2010; Denver, CO.
12. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354(9177):447-455.
13. Tavazzi L, Maggioni AP, Marchioli R, et al; Gissi-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1223-1230.
14. Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol. 2007;99(6A):35C-43C.
15. Pratt CM, Reiffel JA, Ellenbogen KA, Naccarelli GV, Kowey PR. Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study. Am Heart J. 2009;158(2):163-169.
16. Muhammad KI, Morledge T, Sachar R, Wolski K, Bhatt DL. Treatment with omega-3 fatty acids reduces serum C-reactive protein levels: results from a randomized, double-blinded, placebo-controlled trial. Paper presented at: the American College of Cardiology meeting; March 29-31, 2009; Orlando, FL. Abstract 1021-79.
17. Marchioli R, Barzi F, Bomba E, et al; GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105(16):1897-1903.
18. Ninio DM, Murphy KJ, Howe PR, Saint DA. Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model. J Cardiovasc Electrophysiol. 2005;16(11):1189-1194.
19. Sarrazin JF, Comeau G, Daleau P, et al. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol. 2007;50(15):1505-1512. (Pubitemid 47494587)
20. Mavrakis HE, Kanoupakis EM, Kallergis EM, et al. Evaluation of the omega-3 fatty acids acute electrophysiological effects in human atrial myocardium. Heart Rhythm. 2007;4:S184.
21. Kumar S, Sutherland F, Rosso R, et al. Chronic fish oil ingestion in humans prevents atrial electrical remodeling and reduces susceptibility to atrial fibrillation. Heart Rhythm. 2010;7:S108-S109.
22. Biscione F, Totteri A, De Vita A, Lo Bianco F, Altamura G. Effect of omega-3 fatty acids on the prevention of atrial arrhythmias [in Italian]. Ital Heart J Suppl. 2005;6(1):53-59.
23. Nodari S, Manerba A, Madureri N, et al. Effects of polyunsaturated fatty acids n-3 (PUFA n-3) in the prophylaxis of atrial fibrillation relapses after external electric cardioversion P5161. Eur Heart J. 2006 (abstract suppl) 887.
24. Heidarsdottir R, Arnar DO, Skuladottir GV, et al. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace. 2010;12(3):356-363.
25. Heidt MC, Vician M, Stracke SK, et al. Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. Thorac Cardiovasc Surg. 2009;57(5):276-280.
26. Berry JD, Prineas RJ, van Horn L, et al. Dietary fish intake and incident atrial fibrillation (from the Women's Health Initiative). Am J Cardiol. 2010;105(6):844-848.